BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • BCI
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Tuesday, June 30, 2026
Home » Authors » Amanda Pedersen

Amanda Pedersen

Articles

ARTICLES

Northstar gets OK to start Renova trial for depression

Oct. 16, 2008
By Amanda Pedersen

Medtronic launches PEEK version of X-Stop IPD device

Oct. 15, 2008
By Amanda Pedersen

Study aims to assess impact of personal genetic screening

Oct. 14, 2008
By Amanda Pedersen

FDA approves W.L. Gore's EMBOLDEN filter study

Oct. 13, 2008
By Amanda Pedersen

FDA clears magnetic device for treatment of depression

Oct. 9, 2008
By Amanda Pedersen
Adults who suffer from depression may be able to try a new type of therapy, transcranial magnetic stimulation (TMS), when antidepressant medication fails to work. Neuronetics (Malvern, Pennsylvania), a private device company, said the FDA has cleared its NeuroStar TMS system for the treatment of depression. (Medical Device Daily)
Read More

Paragon now becomes Nexeon, and gets $24M for Protex study

Oct. 8, 2008
By Amanda Pedersen
Tuesday was the beginning of a new era for Paragon Intellectual Properties (Charleston, West Virginia) as the company reported it has restructured, moving from a limited liability company with seven subsidiaries to a single C-corporation to form Nexeon MedSystems. The company said the change was made to prepare for clinical trials and commercialization of its lead technologies. (Medical Device Daily)
Read More

SutureSafe expected to get a thumbs-up from patients

Oct. 7, 2008
By Amanda Pedersen
Just like a movie doesn't always need to be full of special effects to be a hit at the box office, a medical device doesn't always need to be complex to get a rave review. A perfect example is the latest product from Canica Design (Almonte, Ontario), an R&D company specializing in wound closure systems. (Medical Device Daily)
Read More

FDA OKs beneath-the-skin catheter securement device

Oct. 6, 2008
By Amanda Pedersen
When Michael Rosenberg, MD, was training for interventional radiology he noticed on the nights he was on call that he frequently was called because a patient's catheter, which was secured either by sutures or an adhesive device, such as tape, had become dislodged. (Medical Device Daily)
Read More

Deals roundup: Hill-Rom buys Swedish maker of lifts and slings for $183M

Oct. 3, 2008
By Amanda Pedersen
Hill-Rom (Batesville, Indiana) said it has acquired Liko (Lulea, Sweden), a developer of lifts and slings designed for the safe movement of patients, for $183 million. (Medical Device Daily)
Read More

InTempo for CyberKnife aims to boost prostate tracking

Oct. 2, 2008
By Amanda Pedersen
View All Articles by Amanda Pedersen

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for June 29, 2026.
  • Illustration for mutations in the DNA leading to brain diseases or neurodegenerative disorders

    ENCALS 2026: From genetics to advancing strategies against ALS

    BioWorld Science
    Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
  • Subsense BCI platform

    Next wave of BCI firms builds on pioneers to tackle challenges

    BioWorld
    With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
  • Handshake with DNA, molecules

    Elixirgen and Nippon Shinyaku sign EXG-7001 option agreement

    BioWorld Science
    Elixirgen Therapeutics Inc. has entered into an option agreement with Nippon Shinyaku Co. Ltd. for the development and commercialization of EXG-7001 for Duchenne...
  • Digital brain with dollar sign

    Investors bet on transformative BCI tech for neuro disorders

    BioWorld
    An estimated $2 billion has been invested in the brain-computer interface (BCI) space in the last two years and the level of funding is expected to continue....
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing